This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignees: Bikenbiomics Co., Ltd., Osaka University. Active years: 2020.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:

Years Active: 2020
Title: Hiroya Oki: Innovator in Peptide Research
Introduction
Hiroya Oki is a notable inventor based in Suita, Japan. He has made significant contributions to the field of peptide research, particularly in the development of a peptide that inhibits the colonization of pathogenic bacteria in digestive organs. His innovative work has implications for improving health and preventing infections.
Latest Patents
Hiroya Oki holds a patent titled "Peptide inhibiting colonization by pathogenic bacteria, and colonization inhibitor including same." This patent describes a peptide capable of preventing pathogenic bacteria from colonizing in digestive organs. The peptide comprises a first domain with an amino acid sequence that binds to a minor pilin of IVb fimbriae, and a second domain that allows for multimerization. The second domain is connected to the first domain via a linker sequence. This invention has the potential to enhance digestive health and combat bacterial infections.
Career Highlights
Throughout his career, Hiroya Oki has worked with prominent organizations such as Bikenbiomics Co., Ltd. and Osaka University. His experience in these institutions has allowed him to collaborate with leading researchers and contribute to advancements in his field.
Collaborations
Hiroya Oki has collaborated with notable colleagues, including Takuya Yoshida and Shunsuke Fukakusa. These partnerships have fostered a productive research environment and have led to significant advancements in peptide technology.
Conclusion
Hiroya Oki's innovative work in peptide research exemplifies the importance of scientific advancements in health. His contributions, particularly in developing a peptide that inhibits pathogenic bacteria, highlight the potential for improving digestive health and preventing infections.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile